Medical management of parapneumonic pleural disease

Pediatr Pulmonol. 2005 Feb;39(2):127-34. doi: 10.1002/ppul.20127.

Abstract

Considerable heterogeneity exists in the management of parapneumonic pleural disease. A randomized controlled trial (RCT) demonstrated the effectiveness of small-catheter drainage with fibrinolysis, but surgical devotees suggest this may only be applicable to "early" cases. We examined evidence-based medical management in "all-comers." We performed a retrospective database analysis of the management of all children with complex pleural effusion admitted to the John Radcliffe Hospital over the 7-year period 1996-2003. One hundred and ten children were admitted. Ten were excluded as they were part of a multicenter RCT and had received intrapleural saline instead of urokinase. Of the remaining 100, 51 were female and 49 male. Median age on admission was 5.8 years (range, 0.3-16.5). Symptoms preadmission averaged 11 days, with December the most common month for presentation. Ninety-six underwent chest ultrasound, confirming an effusion in all, described as loculated/septated (68) or echogenic (11). In 17 cases, no specific comment was made regarding the nature of the fluid seen on ultrasound. Ninety-five had subsequent chest tube drainage and then received intrapleural fibrinolysis with urokinase. An etiological organism was identified in 21 cases (21%) (Streptococcus pneumoniae in 10, group A Streptococcus in 5, Staphylococcus aureus in 4, Haemophilus influenzae in 1, and coliform in 1). In a further 9 cases (9%), Gram-positive organisms were seen on pleural fluid microscopy, but did not grow on culture. Two (2%) required surgery due to the persistence of symptoms and an inadequate response to medical management. Median duration of admission was 7 days (range, 2-21 days); median duration of stay from intervention was 5 days (range, 2-19 days). At median follow-up of 8 weeks (range, 3-20 weeks), all children were symptom-free, with minimal pleural thickening on chest X-ray. In conclusion, antibiotic therapy with chest drain insertion and intrapleural urokinase is effective in treating complex parapneumonic effusion and is associated with a good long-term outcome.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / administration & dosage
  • Cefuroxime / administration & dosage
  • Chest Tubes
  • Child
  • Child, Preschool
  • Double-Blind Method
  • Drainage / instrumentation*
  • Empyema, Pleural / diagnosis
  • Empyema, Pleural / etiology
  • Empyema, Pleural / therapy*
  • Extracellular Fluid / microbiology
  • Female
  • Follow-Up Studies
  • Gram-Positive Bacteria / isolation & purification
  • Gram-Positive Bacterial Infections / diagnosis
  • Gram-Positive Bacterial Infections / microbiology
  • Gram-Positive Bacterial Infections / therapy
  • Humans
  • Infant
  • Injections, Intravenous
  • Instillation, Drug
  • Length of Stay
  • Male
  • Plasminogen Activators / administration & dosage*
  • Pleural Cavity / diagnostic imaging
  • Pleural Effusion / diagnosis
  • Pleural Effusion / microbiology
  • Pleural Effusion / therapy
  • Pneumonia, Bacterial / complications*
  • Pneumonia, Bacterial / diagnostic imaging
  • Radiography, Thoracic
  • Retrospective Studies
  • Thoracotomy
  • Treatment Outcome
  • Ultrasonography
  • Urokinase-Type Plasminogen Activator / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator
  • Cefuroxime